Paul K.Y. Lam
University of Hong Kong
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paul K.Y. Lam.
Laryngoscope | 2006
Paul K.Y. Lam; Karen M Chan; Wai-Kuen Ho; Elaine Kwong; Edwin M.-L. Yiu; William I. Wei
Objectives/Hypothesis: Recent developments in voice assessment propose the use of quality of life measurements. The Voice Handicap Index (VHI) is one of the most psychometrically robust and well‐studied instruments among the various instruments for measuring quality of life. Two versions of VHI (VHI‐30 and VHI‐10) have been shown to be valid instruments for distinguishing dysphonic from nondysphonic individuals and also for documenting treatment effect for dysphonic patients. The VHI has been used worldwide; however, the psychometric properties of the Chinese version of VHI remains untested. This study aimed to investigate such properties of the Chinese VHI‐30 and VHI‐10 in the Hong Kong Chinese population.
Clinical Gastroenterology and Hepatology | 2010
Paul K.Y. Lam; Manwa L. Ng; Ting K. Cheung; Birgitta Yee-Hang Wong; Victoria P. Tan; Daniel Tik-Pui Fong; William I. Wei; Benjamin C.Y. Wong
BACKGROUND & AIMS There is controversy about the efficacy of treating patients with laryngopharyngeal reflux (LPR) using proton pump inhibitors (PPIs). We assessed the effects of high doses of the PPI rabeprazole in patients with LPR. METHODS Patients with LPR symptoms were assigned randomly to receive rabeprazole (20 mg, twice daily, n = 42) or placebo (n = 40) for 12 weeks. All patients completed symptom questionnaires; these provided demographic information and the reflux symptom index before, during, and 6 weeks after cessation of treatment. Videolaryngostroboscopy was used to document the laryngeal findings and determine the reflux finding score. RESULTS Twenty-four patients (57.1%) in the rabeprazole group and 27 patients (67.5%) in the placebo group had pH-documented LPR. The total reflux symptom index score decreased significantly in the group given rabeprazole, compared with patients given placebo, at weeks 6 and 12, but not at week 18. However, there were no significant differences in reflux finding scores between the rabeprazole and placebo groups at any of the time points. CONCLUSIONS Twelve weeks of treatment with rabeprazole (20 mg, twice daily) significantly improved reflux symptoms, compared with placebo, in patients with LPR. Relapse of symptoms was observed 6 weeks after stopping PPI therapy, indicating the requirement for longer treatment duration in patients with LPR.
Journal of Laryngology and Otology | 2002
Paul K.Y. Lam; Nigel J. Trendell-Smith; Jimmy H.C. Li; Yiu Wah Fan; Anthony Po Wing Yuen
Myxofibrosarcoma was originally described as the myxoid variant of malignant fibrous histiocytoma (MFH). It is uncommon in the head and neck region. We hereby report a case of myxofibrosarcoma in the sphenoid sinuses. The diagnostic and management difficulties are discussed. Close collaboration between surgeon, radiologist, histopathologist and clinical oncologist in makng accurate diagnosis and appropriate management of this rare tumour are emphasized.
Digestion | 2009
Ting Kin Cheung; Paul K.Y. Lam; William I. Wei; Wai Man Wong; Manwa L. Ng; Qing Gu; Ivan Fan-Ngai Hung; Benjamin C.Y. Wong
Background: Laryngopharyngeal reflux (LPR) disease is an extraesophageal manifestation of gastroesophageal reflux disease (GERD). The impact of GERD-related LPR on the psychological well-being and quality of life (QOL) in Chinese is not known. Aim: To assess the QOL in patients with LPR disease. Methods: 76 LPR and 73 healthy subjects were recruited. Psychological well-being was assessed by the Hospital Anxiety and Depression Score and QOL was assessed by SF-36. Results: 51/76 (67.1%) patients had GERD-related LPR. More LPR subjects had taken sick leave (36.2 vs. 5.6%, p = 0.001) and reported adverse social life impact (60.5 vs. 38.9%, p = 0.013). LPR patients showed significantly worse results on the Voice Handicap Index (47.8 vs. 7.6, p = 0.001), were more anxious and had worse QOL in social functioning, pain and general health perception domains of SF-36. GERD-related LPR subjects had a higher depression score (4.8 vs. 3.8, p = 0.014) and a lower mental summary score (41.8 vs. 48.4, p = 0.01) in SF-36 compared with those without GERD. Conclusions: LPR had a negative impact on psychological status, social functioning and QOL. GERD symptoms appeared to be the main contributor to decrease QOL. GERD-related LPR patients had a significant impact on the mental component of their QOL.
Otolaryngology-Head and Neck Surgery | 2007
Paul K.Y. Lam; Wai-Kuen Ho; Manwa L. Ng; William I. Wei
Objective To justify the application of medialization thyroplasty in Chinese patients with symptomatic cancer-related unilateral vocal fold paralysis (UVFP). Study Design and Setting Retrospective chart review from February 2000 to March 2006. Results Eighty-seven Chinese patients undergoing medialization thyroplasty for UVFP were included; there were no significant differences between the cancer-related and benign groups in terms of the speech and swallowing rehabilitation outcome and the perioperative complication rate (P > 0.05). The median survival time of cancer-related UVFP patients from the date of medialization to death was 129 days. Age more than 65 years was identified as the only factor for a shorter survival period after medialization (P = 0.040). Conclusion Medialization thyroplasty restores satisfactory speech and swallowing and has a low perioperative complication rate in Chinese patients with cancer-related UVFP. Postmedialization survival period was also reasonable. Significance Medialization thyroplasty is a justifiable treatment option for cancer-related UVFP.
Auris Nasus Larynx | 2009
Manwa L. Ng; Hanjun Liu; Qin Zhao; Paul K.Y. Lam
OBJECTIVE In Hong Kong, esophageal (SE), tracheoesophageal (TE), electrolaryngeal (EL), and pneumatic artificial laryngeal (PA) speech are commonly used by laryngectomees as a means to regain verbal communication after total laryngectomy. While SE and TE speech has been studied to some extent, little is known regarding the EL and PA sound quality. The present study examined the sound quality associated with SE, TE, EL, and PA speech, and compared with that associated with laryngeal (NL) speech by using long-term average speech spectra (LTAS). METHODS Continuous speech samples of reading a 136-word passage were obtained from NL, SE, TE, EL, and PA speakers of Cantonese. The alaryngeal speakers were all superior speakers selected from the New Voice Club of Hong Kong, which is a self-help organization for the laryngectomees in Hong Kong. TE speakers were fitted with Provox valve, and EL speakers used Servox-type electrolarynx. Speech samples were digitized at 20kHz and 16bits/sample by using Praat, based on which LTAS contours were developed. First spectral peak (FSP), mean spectral energy (MSE), and spectral tilt (ST) derived from the LTAS contours associated with different speaker groups were compared. RESULTS Data revealed all speakers generally exhibited similar LTA contours. However, PA speakers exhibited the lowest average FSP value and the greatest average MSE value. NL phonation was associated with a significantly greater ST value than alaryngeal speech of Cantonese. CONCLUSION The differences in FSP, MSE, and ST values in different speaker groups may be related to the different sound sources being used by the laryngectomees, and the difference in the way the sound source is coupled with the vocal tract system.
Folia Phoniatrica Et Logopaedica | 2012
Nan Yan; Paul K.Y. Lam; Manwa L. Ng
Objective: Previous studies of English-speaking esophageal (SE) and tracheoesophageal (TE) speakers revealed a significantly lower voice fundamental frequency (F0) than normal laryngeal (NL) speakers. Studies of SE and TE speakers of a tone language, however, indicated discrepant findings. Tonal SE and TE speakers could produce comparable or even higher F0 than NL speakers. The present study examined the F0 characteristics associated with speech and nonspeech tasks produced by Cantonese SE and TE speakers. Subjects and Methods: Speech produced by 15 superior SE, 15 superior TE and 15 NL speakers was recorded while each was reading a short passage and performing a pitch scaling task. F0 values were calculated from the speech samples. Results: SE speakers had higher average F0 in reading tasks than TE and NL speakers, while the NL speakers exhibited the highest average F0 values followed by SE and TE speakers during pitch scaling. In addition, pitch scaling (nonspeech) tasks were associated with higher average F0 than passage reading tasks regardless of speaker type. Conclusion: The findings point to the fact that, despite the use of the new sound source, SE and TE speakers were still able to change F0 for specific speech tasks.
Folia Phoniatrica Et Logopaedica | 2018
Manwa L. Ng; Nan Yan; Venus Chan; Yang Chen; Paul K.Y. Lam
Objective: Previous studies of the laryngectomized vocal tract using formant frequencies reported contradictory findings. Imagining studies of the vocal tract in alaryngeal speakers are limited due to the possible radiation effect as well as the cost and time associated with the studies. The present study examined the vocal tract configuration of laryngectomized individuals using acoustic reflection technology. Subjects and Methods: Thirty alaryngeal and 30 laryngeal male speakers of Cantonese participated in the study. A pharyngometer was used to obtain volumetric information of the vocal tract. All speakers were instructed to imitate the production of /a/ when the length and volume information of the oral cavity, pharyngeal cavity, and the entire vocal tract were obtained. The data of alaryngeal and laryngeal speakers were compared. Results: Pharyngometric measurements revealed no significant difference in the vocal tract dimensions between laryngeal and alaryngeal speakers. Conclusion: Despite the removal of the larynx and a possible alteration in the pharyngeal cavity during total laryngectomy, the vocal tract configuration (length and volume) in laryngectomized individuals was not significantly different from laryngeal speakers. It is suggested that other factors might have affected formant measures in previous studies.
Folia Phoniatrica Et Logopaedica | 2012
Nan Yan; Paul K.Y. Lam; Manwa L. Ng; R. Filippini; D.M. Befi-Lopes; E. Schochat; Meropi E. Helidoni; Thomas Murry; Gregory Chlouverakis; Areti Okalidou; George A. Velegrakis; Lovisa Femrell; Marita Åvall; Elisabeth Lindström; Tanja Etz; Henning Reetz; Carla Wegener; Tobias Weißgerber; Uwe Baumann; Thomas Brand; Katrin Neumann; Tom H. Karlsen; Anne Rita Hella Grieg; John-Helge Heimdal; Hans Jørgen Aarstad; Satz Mengensatzproduktion; Druck Reinhardt Druck Basel
Each paper needs a structured abstract of 200 words in English. It should be structured as follows: – Objective – Patients and Methods – Results – Conclusion Footnotes: Avoid footnotes. Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be sent in separate files. Tables require a heading and figures a legend, also in a separate file. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations in one block for reproduction (max. size 180 223 mm). Black and white halftone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1,200 dpi. Color illustrations Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends. Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 800.– per page. References: In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as ‘unpublished data’ and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org). Examples (a) Papers published in periodicals: Chatel J-M, Bernard H, Orson FM: Isolation and characterization of two complete Ara h 2 isoforms cDNA. Int Arch Allergy Immunol 2003;131:14–18. (b) Papers published only with DOI numbers: Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858. (c) Monographs: Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 3, revised. Basel, Karger, 1996. (d) Edited books: Hone SW, Smith RJH: Understanding inner ear physiology at the molecular level; in Cremers Cor WRJ, Smith RJH (eds): Genetic Hearing Impairment. Adv Otorhinolaryngol. Basel, Karger, 2002, vol 61, pp 1–10. Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists. Supplementary Material Supplementary material is restricted to additional data that are not necessary for the scientific integrity and conclusions of the paper. Please note that all supplementary files will undergo editorial review and should be submitted together with the original manuscript. The Editors reserve the right to limit the scope and length of the supplementary material. Supplementary material must meet production quality standards for Web publication without the need for any modification or editing. In general, supplementary files should not exceed 10 MB in size. All figures and tables should have titles and legends and all files should be supplied separately and named clearly. Acceptable files and formats are: Word or PDF files, Excel spreadsheets (only if the data cannot be converted properly to a PDF file), and video files (.mov, .avi, .mpeg). Digital Object Identifier (DOI) S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org Author’s ChoiceTM Karger’s Author’s ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www. karger.com. The option is available for a one-time fee of CHF 3000.–, which is a permissible cost in grant allocation. More information can be found at www.karger.com/ authors_choice. NIH-Funded Research The U.S. National Institutes of Health (NIH) mandates under the NIH Public Access Policy that final, peer-reviewed manuscripts appear in its digital database within 12 months of the official publication date. As a service to authors, Karger submits the final version of your article on your behalf to PubMed Central. For those selecting our premium Author’s ChoiceTM service, we will send your article immediately upon publishing, accelerating the accessibility of your work without the usual embargo. More details on NIH’s Public Access Policy is available at http://publicaccess.nih.gov/policy.htm Self-Archiving Karger permits authors to archive their pre-prints (i.e. pre-refereeing) or post-prints (i.e. final draft post-refereeing) on their personal or institution’s servers, provided the following conditions are met: Articles may not be used for commercial purposes, must be linked to the publisher’s version, and must acknowledge the publisher’s copyright. Authors selecting Karger’s Author’s ChoiceTM feature, however, are also permitted to archive the final, published version of their article, which includes copyediting and design improvements as well as citation links. Page Charges There are no page charges for papers of 5 or fewer printed pages (including tables, illustrations and references). Each additional complete or partial page is charged to the author at CHF 650.–. The allotted size of a paper is equal to approx. 16 manuscript pages (double-spaced, A4, including tables, illustrations and references). Proofs Unless indicated otherwise, proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations other than the correction of printer’s errors are charged to the author. Reprints Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices. Guidelines for Authors
Otolaryngology-Head and Neck Surgery | 2007
Paul K.Y. Lam
PROBLEM: Treatments for ADSD include botulinum toxin injections (botox), surgery, and/or voice therapy. Botox injections remain the gold standard treatment to reduce symptoms of ADSD. Improvements in vocal function have been reported after use of botox injections though a completely normal voice is rarely achieved. There is not a standardized, validated scale for measuring perceptual voice changes after botox injection. Problems arise when there is disagreement on the effectiveness of a treatment. The purpose of this phase one-study is to document clinician-patient agreement of the effects of botox injection on voice quality and quality of life in the ADSD population. METHODS: Retrospective chart review of 88 patients receiving botox injections. Clinicians’ perceptual ratings of vocal quality using the Consensus Auditory Perceptual Evaluation of Voice (CAPE-V), a 100 mm VAS scale, were compared with patients’ ratings of voice quality using a 7 point EIS. Patient perception of the impact of the botox injection on quality of life utilizing the Voice Related Quality of Life (VRQOL) was compared with voice quality ratings from the CAPE-V and 7 point EIS. RESULTS: There was a weak correlation (r2 0.29) between the VRQOL and the CAPE-V. There was a weak correlation (r2 0.44) between the EIS and VRQOL. While the correlation was stronger between the CAPE-V and the EIS, it remained weak at (r2 0.49). CONCLUSION: The poor relationship among commonly used outcome measures leads the researchers to question how best to assess the effectiveness of botox in ADSD. Clinicians are required to document treatment outcomes making it important to utilize scales that are valid, reliable and sensitive to change. SIGNIFICANCE: This study is the first in a series of studies whose aim is to develop a valid, reliable, and accurate measurements of the effectiveness of botulinum toxin injections for the treatment of ADSD.